The new TRT program and brand identity marks the next chapter for the company that has treated more than 400,000 patients with its performance-driven health solutions
Rugiet, a fast-growing men’s health company, has announced the launch of its testosterone replacement therapy (TRT) program, marking a significant expansion beyond its flagship erectile dysfunction treatments. The move signals Rugiet’s evolution into a broader performance-driven healthcare brand focused on improving men’s health through accessible, clinician-guided medical solutions.
Health Technology Insights: https://healthtechnologyinsights.com/ai-in-therapy-and-behavioral-health-technologies-driving-better-care/
The company, which surpassed $100 million in revenue in 2025, introduced the new therapy alongside a refreshed brand identity that reflects its long-term vision of becoming a comprehensive destination for men’s health and performance care. By expanding into testosterone therapy, Rugiet aims to address a growing demand for personalized treatments that support hormonal balance, sexual health, and overall well-being.
Rugiet’s TRT program includes multiple treatment options designed to meet diverse patient needs. These options include enclomiphene therapy as well as oral, injectable, and topical testosterone replacement treatments. Each treatment plan is supported by comprehensive lab testing, physician consultations, and individualized medical evaluations to ensure safe and effective patient outcomes.
Health Technology Insights: https://healthtechnologyinsights.com/what-are-health-apps-and-how-do-they-help-daily-life/
Since its founding in 2020, Rugiet has been widely recognized for its science-backed men’s health solutions, particularly its innovative 3-in-1 erectile dysfunction treatment Ready®. As the company expanded its patient base, Rugiet identified a growing connection between physical performance, hormonal health, and psychological well-being. This insight helped shape its broader healthcare strategy aimed at addressing underlying medical factors that often contribute to sexual health concerns.
Rugiet’s CEO, Mike Apostal, highlighted the company’s healthcare solutions’ logical growth. According to Apostal, “hundreds of thousands of men trust Rugiet to help them with their performance in the bedroom, which has uncovered additional areas of health that frequently go hand-in-hand with erectile dysfunction and may signal broader health issues.” “As we create a unique destination for men seeking to take charge of their health, entering testosterone therapy is a natural next step.”
Recent clinical research continues to highlight the growing relevance of hormone health in modern medicine. Studies published in leading medical journals have documented generational declines in testosterone levels, independent of aging. At the same time, prescription rates for testosterone therapies have increased significantly among younger men seeking proactive health management.
Dr. Nicholas Farber, a urologist specializing in men’s health and sexual medicine and a member of Rugiet’s medical advisory board, noted the importance of improving access to structured, clinically guided TRT programs. According to Dr. Farber, Rugiet’s approach introduces a scalable, physician-supervised care model that bridges the gap between traditional clinical care and accessible digital health services.
Alongside the therapy launch, Rugiet unveiled a complete brand transformation designed to modernize the men’s healthcare category. Developed in collaboration with Pentagram for brand identity and Alright Studio for digital design, the new visual identity reflects Rugiet’s focus on clinical rigor, confidence, and its commitment to “Performance Medicine for Men.”
Through the expansion of testosterone therapy services and a renewed brand vision, Rugiet is positioning itself as a leader in next-generation men’s healthcare, delivering personalized treatments that empower patients to improve both performance and long-term health outcomes.
Health Technology Insights: https://healthtechnologyinsights.com/genomic-ai-how-artificial-intelligence-is-powering-dna-based-nutrition-and-therapy/
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
